ABLi Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch ABLi Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A PK Study of IkT-148009 in Older and Elderly Healthy Subjects (NCT06644326) | ABLi Therapeutics, Inc. | 2023-06-21 |
| A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease (NCT05424276) | ABLi Therapeutics, Inc. | 2023-05-15 |
| A Phase I Dosing Study of IkT-148009. (NCT06641557) | ABLi Therapeutics, Inc. | 2023-02-21 |
| A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients (NCT04350177) | ABLi Therapeutics, Inc. | 2021-02-16 |
Track ABLi Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.